Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares OutstandingShort-Term Debt repayments
Ratios

BioNexus Gene Lab (BGLC) Cost of Revenue (2018 - 2025)

BioNexus Gene Lab's Cost of Revenue history spans 8 years, with the latest figure at $4.6 million for Q4 2025.

  • Quarterly results put Cost of Revenue at $4.6 million for Q4 2025, down 30.61% from a year ago — trailing twelve months through Dec 2025 was $8.0 million (down 14.28% YoY), and the annual figure for FY2025 was $6.3 million, down 22.89%.
  • Cost of Revenue for Q4 2025 was $4.6 million at BioNexus Gene Lab, up from $2.2 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $6.7 million in Q4 2024 to a low of -$5.8 million in Q4 2023.
  • The 5-year median for Cost of Revenue is $2.3 million (2022), against an average of $1.9 million.
  • The sharpest move saw Cost of Revenue crashed 333.48% in 2023, then surged 345.75% in 2025.
  • Year by year, Cost of Revenue stood at $2.8 million in 2021, then decreased by 9.67% to $2.5 million in 2022, then crashed by 333.48% to -$5.8 million in 2023, then skyrocketed by 214.51% to $6.7 million in 2024, then tumbled by 30.61% to $4.6 million in 2025.
  • According to Business Quant data, Cost of Revenue over the past three periods came in at $4.6 million, $2.2 million, and $608427.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.